How new approaches to patient care can ease NHS pressures
There is no doubt that COVID-19 has changed the world, forever. This is particularly true of the NHS and patient care. Going forward, care...
How NHS funding and finances are changing patient pathways
COVID-19 has been a catalyst for change in NHS finance where a new ‘system-level’ funding arrangement has been introduced in England. This sees providers...
Community pharmacy as the front door
We’re facing a very tough winter. No matter where you are, or what you do, the COVID-19 pandemic is affecting the health of us...
COVID-19 and the counterfeit drug crisis
The threat posed to the pharmaceutical industry by counterfeit drugs medicines is on the rise - and could be set to get worse unless...
Distribution and scaling up a Covid-19 vaccine
The development and distribution of a safe and effective vaccine is widely seen as the best resolution to the COVID-19 pandemic, and the most...
Implications of early COVID-19 vaccine data
News this week has largely been dominated by talk about a COVID-19 vaccine and finnCap’s Rude Health Life Sciences Sector Report is one of...
Ten top tips for pharma and healthcare to avoid data breaches
Every organisation is a software organisation but for healthcare providers and pharmaceutical organisations, the stakes are high when it comes to data breaches. In...
The importance of security for medical device firms
With news hitting the headlines that global pharmaceutical company Pfizer Inc. has suffered a huge data breach and in light of National Cyber Security...
Project management matters
Rebecca Fox, Head of Membership at the Association for Project Management (APM), looks at how projects and project-related skills have taken on a new...
Challenges in recruiting during the pandemic
Richard Clegg, Director of Expion Search and Selection, looks at how COVID-19 has presented many challenges to industry, not least in recruitment and retention...
Latest articles
Pre-clinical work completed for novel COVID-19 immunotherapy
ISA Pharmaceuticals has announced that it has completed pre-clinical work for ISA106, a novel COVID-19 immunotherapy and is planning clinical trials. A phase 1...
Ashfield shakes up healthcare services with advanced integrated offering
Ashfield, part of UDG Healthcare plc, has announced the formation of three business units to bolster its integrated healthcare services across strategic consulting, benchmarking,...
Cancer Research UK and Teon collaborate on cancer drug
Cancer Research UK and Teon have signed a collaboration agreement to progress the early phase clinical development of Teon’s first-in-class small molecule adenosine A2B receptor antagonist, TT-702.
Under the terms of the...
Popular articles
New Normal, New Thinking: Life Post COVID-19
New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours
A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...
NHS prescription charge to increase from 1 April 2021
The NHS prescription charge will increase to £9.35 per prescription item from 1 April 2021 in England, according to the Pharmaceutical Services Negotiating Committee...
New consultancy specialising in healthcare innovation launches
Today sees the launch of Newmarket Strategy, a strategic and technical advisory business specialising in healthcare and life sciences. This new venture brings together three...
Understanding the role of the MSL
Helen Kane surveyed more than 200 medical science liaisons (MSLs) to understand more about their current in-role reality. She gave Pf Magazine exclusive access...